AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 221 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $10,644,000 | +4716.3% | 300 | -90.9% | 0.06% | +6200.0% |
| Q1 2019 | $221,000 | -22.5% | 3,291 | -11.2% | 0.00% | 0.0% |
| Q3 2018 | $285,000 | -9.5% | 3,706 | -0.8% | 0.00% | -50.0% |
| Q2 2018 | $315,000 | +7.5% | 3,737 | +4.7% | 0.00% | 0.0% |
| Q1 2018 | $293,000 | +5.8% | 3,570 | -47.4% | 0.00% | 0.0% |
| Q1 2016 | $277,000 | -37.3% | 6,793 | -0.4% | 0.00% | -33.3% |
| Q4 2015 | $442,000 | -20.2% | 6,818 | -13.0% | 0.00% | -25.0% |
| Q3 2015 | $554,000 | -7.2% | 7,833 | +45.6% | 0.00% | 0.0% |
| Q2 2015 | $597,000 | -7.2% | 5,379 | -30.1% | 0.00% | 0.0% |
| Q1 2015 | $643,000 | -3.2% | 7,699 | +14.1% | 0.00% | 0.0% |
| Q4 2014 | $664,000 | +110.8% | 6,750 | +31.6% | 0.00% | +100.0% |
| Q3 2014 | $315,000 | – | 5,130 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |